Traynor Capital Management, Inc. Tandem Diabetes Care Inc Transaction History

Traynor Capital Management, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Jan 24, 2020	SELL	$53.13 - $71.19 $560,415 - $750,912	-10,548 Closed	0 $0
Q3 2019 Nov 01, 2019	SELL	$57.11 - $73.3 $50,256 - $64,504	-880 Reduced 7.7%	10,548 $622,000
Q1 2019 Apr 12, 2019	BUY	$32.25 - $73.56 $368,553 - $840,643	11,428 New	11,428 $725,000
Q4 2018 Jan 24, 2019	SELL	$28.45 - $40.65 $950,884 - $1.36 Million	-33,423 Closed	0 $0
Q3 2018 Oct 24, 2018	BUY	$21.39 - $51.17 $8,834 - $21,133	413 Added 1.25%	33,423 $1.43 Million
Q2 2018 Aug 03, 2018	BUY	$4.9 - $23.64 $161,749 - $780,356	33,010 New	33,010 $706,000

360

72.5M

3.36M

229K

Ticker TNDM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 64,221,200
Market Cap $1.98B
Description
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...

Get notified when there are updates to the investment portfolio of Traynor Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Traynor Capital Management, Inc. with notifications on news.